A European rival to SpaceX is chasing a $2B valuation

European founders who run out of seed money usually know where they’re headed next: a flight to San Francisco or New York. That pattern has held for a decade across software and biotech, and it has quietly decided who ends up owning Europe’s most promising companies once they get big. The ...